» Authors » Golnar Rahimzadeh

Golnar Rahimzadeh

Explore the profile of Golnar Rahimzadeh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 141
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rahimzadeh G, Ghezljai N, Rezai S, Rezai R, Navaiefar M, Rezai M, et al.
Adv Biomed Res . 2025 Feb; 13:123. PMID: 40007729
Background: During the COVID-19 pandemic, the widespread and indiscriminate prescription of antibiotics led to a significant increase in antibiotic resistance and the emergence of multi-drug-resistant (MDR) strains. This study aims...
2.
Rahimzadeh G, Rezai S, Abbasi G, Soleimanpour S, Valadan R, Vahedi L, et al.
Iran J Microbiol . 2024 Dec; 16(6):745-754. PMID: 39737355
Background And Objectives: is a common pathogen associated with healthcare-related infections. It is particularly notable for its ability to develop resistance to multiple antibiotics, making treatment challenging. During the COVID-19...
3.
Rahimzadeh G, Rezai S, Valadan R, Rezai R, Soleimanpour S, Vahedi L, et al.
Adv Biomed Res . 2024 Dec; 13:105. PMID: 39717239
Background: Amid the COVID-19 pandemic, the surge in hospital admissions and widespread use of broad-spectrum antibiotics have heightened the risk of hospital-acquired infections from multidrug-resistant (MDR) organisms, particularly . It...
4.
Salimi M, Javidnia J, Abastabar M, Mobayen M, Moslemi A, Rahimzadeh G, et al.
Mycoses . 2024 Aug; 67(8):e13788. PMID: 39166776
Background: Burn patients are at high risk of developing secondary invasive fungal infections due to their compromised skin barrier, extensive use of antibiotics, and immunosuppression. Objectives: We investigated demographic characteristics...
5.
Rahimzadeh G, Valadan R, Rezai S, Khosravi M, Vahedi Larijani L, Sheidaei S, et al.
Iran J Microbiol . 2024 Jul; 16(3):314-322. PMID: 39005594
Background And Objectives: During the coronavirus pandemic, the overuse of antibiotics to reduce coinfections and mortality may be contributing to the rise of antimicrobial resistance. In this study, we aim...
6.
Rahimzadeh G, Rezai M, Farshidi F
Adv Biomed Res . 2023 May; 12:56. PMID: 37200758
is one of the most common bacteria in nosocomial infections. Inappropriate usage of antibiotics has led to expanding emergence resistance to as a multidrug-resistant (MDR) strain. Empirical antibiotic therapy is...
7.
Samaee H, Eslami G, Rahimzadeh G, Saeedi M, Davoudi Badabi A, Asare-Addo K, et al.
J Drug Deliv Sci Technol . 2023 May; 84:104486. PMID: 37123173
Inhalation phage therapy is proposed as a replacement approach for antibiotics in the treatment of pulmonary bacterial infections. This study investigates phage therapy on bacterial pneumonia in patients with moderate...
8.
Rahimzadeh G, Safar M, Rezai S, Rezai M, Movahedi F
Adv Biomed Res . 2023 Jan; 11:97. PMID: 36660762
Background: Congenital infections are among the most important conditions threatening human fetal health, the majority of which are caused by viral agents. Screening pregnant women for viral infections is essential...
9.
Rezai M, Ahangarkani F, Hill A, Ellis L, Mirchandani M, Davoudi A, et al.
Front Med (Lausanne) . 2022 Jul; 9:919708. PMID: 35783616
Background: Ivermectin which was widely considered as a potential treatment for COVID-19, showed uncertain clinical benefit in many clinical trials. Performing large-scale clinical trials to evaluate the effectiveness of this...
10.
Rahimzadeh G, Zazouli M, Rezai M
J Environ Health Sci Eng . 2022 Jun; 20(1):219-225. PMID: 35669812
Purpose: Nosocomial infections can be transmitted by contaminated hospital surfaces with resistant pathogens. is an opportunistic pathogen that causes public healthcare issues. Conventional sanitation is not efficiently contributing to removing...